Pfizer Reports Q4 EPS of $.47 vs. $.46

by Benzinga Staff
February 1, 2011 8:01 AM | 15 seconds read |
Pfizer Inc. PFE today reported financial results for fourth-quarter. Fourth-Quarter 2010 Revenues of $17.6 Billion; Full-Year 2010 Revenues of $67.8 Billion Fourth-Quarter 2010 Adjusted Diluted EPS of $0.47, Reported Diluted EPS of $0.36; Full-Year 2010 Adjusted Diluted EPS of $2.23, Reported Diluted EPS of $1.02
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Date
▲▼
ticker
▲▼
name
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Click to see more Earnings updates
Posted In: EarningsNewsHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!